On October 20-22, 2023, the Aesthetic & Anti-Aging Medicine World Congress (AMWC) was held in Chengdu, Sichuan, China. A wide range of aesthetic plastic surgery products and technologies made their appearance at this event, Wingderm®’s Latest Research of Mesoskin for Mesotherapy Treatment have captured the attention of experts, practitioners, and beauty seekers.

Research of Mesoskin for Mesotherapy Treatment

Professor Hang Wang, the Executive Director of AMWC and Chief of The Department of Plastic Surgery and Cosmetic Dematology, West China stomatological Hospital, Sichuan university, delivered a speech as a guest speaker at the Facial Rejuvenation Forum, with the topic of “Research of Mesoskin for Mesotherapy Treatment”. The EPM technology utilized in Mesoskin from Wingderm® served as the research subject in this clinical trial.

Multiple clinical trial results show that compared to transdermal introduction methods such as nanocrystals, derma rollers, and water injections, EPM technology results in less skin damage, higher permeability and more even subcutaneous hyaluronic acid distribution in the delivery of 150KDa hyaluronic acid, it performs well in both skin experience and treatment efficacy. This research achievement once again reaffirmed the comprehensive advantages of Mesoskin for Mesotherapy Treatment in transdermal delivery.

After the speech, Wingderm® Vice President Ms. Xu Ren presented a certificate to Professor Hang Wang to express gratitude for her significant contributions to Research of Mesoskin. Xu Ren said, Wingderm® will engage in more research and verification of innovative technologies and products that cater to market demands.

About EPM Technology

EPM, introduced by Wingderm® in 2018,creatively combines electroporation and hollow microchip. It aims to improve the absorption rate of nutrients, reduce pain sensation, and enhance the treatment experience. The commercialization of EPM technology resulted in the groundbreaking product Mesoskin, which caused a sensation in the industry as soon as it was launched. This almost painless, non-invasive, and effective treatment method has been recognized and recommended by experts and scholars worldwide and has been widely used global beauty salons and clinics. EPM transdermal introduction represents a breakthrough advancement in the industry and possesses significant market potential.

About Wingderm®

Wingderm® since its establishment in 2016, with the aim of “Aesthetics&Technology, Easy to Achieve”, provide leading and reliable intelligent optoelectronic medical equipments, which are exported to 80+ countries including Europe, America, and the Middle East. 10,000+ devices have been deployed and treated 100,000+ beauty seekers worldwide.

From June 8 to 11, 2023, the international top medical aesthetic event IMCAS was successfully held in Bangkok, Thailand. Wingderm Electro-optics Ltd. (Wingderm®) is once again present as a sponsor and exhibitor of IMCAS.

Wingderm® is showcasing a wide range of devices, including Mesoskin, a highly efficient skincare device, Lasermach, a diode laser hair removal device, Renuva®, Medical Non-ablative Fractional Laser Systems, and Cryoshot®, a skin cooling device that can be used in conjunction with laser devices. Once the product was presented, it quickly attracted the attention of many doctors, beauticians and distributors in the industry. The booth of Wingderm was crowded, and the staff gave a detailed introduction to the technology, safety and effectiveness of the products.

Krystian.Szuba, General Manager of Cryomed & Ebos group, exclusive distributor of Wingderm® in Australia, said: “We are glad to cooperate with Wingderm® because Wingderm® can provide us with high quality products and professional services.”

Krystian.Szuba/General Manager/Cryomed & Ebos group

Wingderm® Vice President Carol Ren said: “As a member of China’s medical aesthetics device industry, Wingderm® is pleased to participate in this international event of the medical aesthetics industry held by IMCAS in Thailand to show the world our cutting-edge products and technologies. During the exhibition, we conducted in-depth exchanges with customers on products and services and reached a number of cooperation programs. These achievements will also lay a solid foundation for Wingderm®’s future development. With the continuous development of the medical aesthetic device industry, the industry value chain is also constantly upgrading. Wingderm® is gradually transforming from a device manufacturer to an overall solution provider in medical aesthetic device industry to meet the all-round needs of partners. Also we provide more personalized services for partners and even end consumers with the help of our self-developed Wingcloud® platform.”

Carol Ren /Vice President /Wingderm®

About Wingderm®

Founded in 2016, with a strong technical foundation and high-end talent base, Wingderm® has successively launched a number of intelligent optoelectronic medical aesthetics equipment. Our devices are adopted by thousands of medical aesthetics institutions in China, and Wingderm® have established a number of sales channels around the world. At present, our company has more than 30 stable distributors in the world, and the globally sold devices has exceeded 10,000 units, and the equipment has been verified by more than 100 million people. In order to ensure that the products can legally enter the global market, Wingderm® products have been certified by the US FDA, the EU CE, the UK, Brazil, Israel, Australia, Russia and other countries.

We always insist on providing efficient intelligent medical equipment service solutions for global customers, combined with the self-built Wingcloud® platform, aiming to guide continuous service improvement and business model innovation, and provide safer and more efficient medical equipment digital management solutions for distributors and equipment users, which has been promoted and verified in more than a dozen countries.